4//SEC Filing
DAWES KAREN A 4
Accession 0000950170-24-022581
CIK 0000730272other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 9:56 PM ET
Size
7.8 KB
Accession
0000950170-24-022581
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
DAWES KAREN A
Director
Transactions
- Sale
Common Stock
2024-02-27$193.35/sh−1,000$193,350→ 87,367 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-27+4,626→ 0 totalExercise: $42.07Exp: 2028-05-16→ Common Stock (4,626 underlying) - Exercise/Conversion
Common Stock
2024-02-27$42.07/sh+4,626$194,616→ 88,367 total
Footnotes (1)
- [F1]This option is fully vested and exercisable.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001261506
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 9:56 PM ET
- Size
- 7.8 KB